S100A8 and pterygium: Although direct study of pterygium or pSS syndromes with anti-S100A8/9 is lacking, the treatment of other diseases effectively reduces a variety of inflammatory factors, which are also involved in ocular immunity, thus suggesting the feasibility of anti-S100A8/9 in the treatment of pterygium or pSS syndromes [47].